Premenstrual syndrome
Conditions
Interventions
Experimental group: 30 women with symptoms of premenstrual syndrome will receive auriculotherapy once a week for 8 weeks and will be followed for 13 weeks. Placebo group: 30 women with symptoms of pre
Other
E02.190.204
Sponsors
Universidade Federal do Paraná
Universidade Federal do Paraná
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: WWomen aged 18-35 years; sedentary; university students enrolled regularly at the Federal University of Paraná; and who have Premenstrual Syndrome (mild to moderate) or Pre-Menstrual Dysphoric Disorder according to the criteria listed in the PSST (Premenstrual Syndrome Screening Tool)
Exclusion criteria
Exclusion criteria: Women classified by PSST as mild or absent Premenstrual Syndrome; in the gestational period; with irregular menstrual cycles (cycles less than 25 days or greater than 35 days); women diagnosed with secondary dysmenorrhea (fibroids, endometriosis or cysts); who have a history of abortion; cardiopathy; who use antidepressants and / or psychotropic medication in the last two months; and, that they have any type of lesion in the auricular pavilion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of the symptoms of premenstrual syndrome in at least 3 of the 14 symptoms listed by the PSST (Premenstrual Syndrome Screenning Tool) questionnaire. Data collected one week before the intervention, the fifth week, the week following the intervention (9th week) and a 4 week follow-up (13th week) | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in pain intensity (measured using the Nordic Symptom Questionnaire), anxiety (measured using the Beck Anxiety Inventory) and quality of life (measured using the WHOQoL-Bref questionnaire). intervention, in the week after the intervention (week 9) and a follow-up of 4 weeks (week 13) | — |
Countries
Brazil
Contacts
Public ContactRaciele Guarda Korelo
Universidade Federal do Paraná
Outcome results
None listed